ResMed (BSP:R1MD34) Cash-to-Debt

: 0.15 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. ResMed's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.15.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, ResMed couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for ResMed's Cash-to-Debt or its related term are showing as below:

BSP:R1MD34' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 0.36 Max: 3.01
Current: 0.15

During the past 13 years, ResMed's highest Cash to Debt Ratio was 3.01. The lowest was 0.11. And the median was 0.36.

BSP:R1MD34's Cash-to-Debt is ranked worse than
89.69% of 863 companies
in the Medical Devices & Instruments industry
Industry Median: 2.08 vs BSP:R1MD34: 0.15

ResMed Cash-to-Debt Historical Data

The historical data trend for ResMed's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

ResMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash-to-Debt

0.12

0.36

0.37

0.30

0.14

ResMed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt																0.13	0.13	0.14	0.14	0.15

Competitive Comparison

For the Medical Instruments & Supplies subindustry, ResMed's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed Cash-to-Debt Distribution

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where ResMed's Cash-to-Debt falls into.

ResMed Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

ResMed's Cash to Debt Ratio for the fiscal year that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1106.115	/	(154.45	+	7513.95)
	=	0.14

ResMed's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1030.168	/	(166.373	+	6651.077)
	=	0.15

ResMed (BSP:R1MD34) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

ResMed Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of ResMed's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (BSP:R1MD34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany RME:Germany RMEA:Germany RME:Germany RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines